Publications and communications of Vincent LAMBERT

Widart, J., Beauvois, V., Lambert, V., Maesen, P., & Hubert, P. (2023). Rapport d'activités RQLab - Année 2022.

Arslan, D., Schoumacher, M., Dilly, S., Elmoualij, B., Zorzi, D., Quatresooz, P., Lambert, V., Noël, A., Pirotte, B., & De Tullio, P. (2023). Design, Synthesis, and Evaluation of Novel Pyruvate Dehydrogenase Kinase Inhibitors. Medicinal Chemistry, 19 (3), 276-296. doi:10.2174/1573406418666220819102627

Widart, J., Beauvois, V., LAMBERT, V., Maesen, P., & Hubert, P. (2022). Rapport d'activités RQLab - Année 2021. autre.

Schoumacher, M., Lambert, V., Govaerts Bernadette, Rakic, J.-M., Noël, A., & De Tullio, P. (2022). From cohort study to the “real life” in patient’s follow-up and personalized medicine using NMR- based clinical metabolomics; results, issues, problems and prospects: the case of neovascular Age-related Macular Degeneration (nAMD) [Poster presentation]. Metabolomics 2022 Valence, valence, Spain.

Roblain, Q., Louis, T., Yip, C., Baudin, L., Struman, I., Caolo, V., LAMBERT, V., Lecomte, J.* , Noël, A.* , & Heymans, S.*. (2021). Intravitreal injection of anti-miRs against miR-142-3p reduces angiogenesis and microglia activation in a mouse model of laser-induced choroidal neovascularization. Aging, 13. doi:10.18632/aging.203035
* These authors have contributed equally to this work.

De Vos, D., Ectors, N., Giet, O., Glorieux, S., Guns, J., Janssens, H., Janssens, R., LAMBERT, V., THONON, F., Vansteenbrugge, A., & Verbeken, G. (2018). CSS 9453 Qualification des salles propres et monitoring des processus aseptiques dans les banques de matériel corporel humain, les structures intermédiaires et les établissements de production. Conseil Supérieur de la Santé.

García Caballero, M., Van De Velde, M., Blacher, S., LAMBERT, V., BALSAT, C., Erpicum, C., Durré, T., Kridelka, F., & Noël, A. (2017). Modeling pre-metastatic lymphvascular niche in the mouse ear sponge assay. Scientific Reports, 7, 41494. doi:10.1038/srep41494

Widart, J., Beauvois, V., Dumont, F., LASRI, S., LAMBERT, V., PIRSON, L., & Hubert, P. (2016). Réseau Qualité des Laboratoire de l'ULg - Rapport d'activité Février 2016.

Arslan, D., Pirotte, B., De Tullio, P., Charif, M. (Other coll.), Dilly, S. (Other coll.), Hansen, S. (Other coll.), LAMBERT, V. (Other coll.), Elmoualij, B. (Other coll.), & Noël, A. (Other coll.). (09 September 2014). AGE-RELATED MACULAR DEGENERATION (AMD): FROM METABOLOMICS APPROACH TO THE INHIBITION OF PDK AS A NEW THERAPEUTIC TARGET [Poster presentation]. XXIII International Symposium on Medicinal Chemistry (EFMC-ISMC 2014), Lisbonne, Portugal.

Detry, B., Blacher, S., Erpicum, C., Paupert, J., Maertens, L., Maillard, C., Munaut, C., Sounni, N. E., LAMBERT, V., Foidart, J.-M., Rakic, J.-M., Cataldo, D., & Noël, A. (2013). Sunitinib inhibits inflammatory corneal lymphangiogenesis. Investigative Ophthalmology and Visual Science, 54 (5), 3082-93. doi:10.1167/iovs.12-10856

Halkein, J., Tabruyn, S. P., Ricke-Hoch, M., Haghikia, A., Nguyen, N.-Q.-N., Scherr, M., Castermans, K., Malvaux, L., Lambert, V., Thiry, M., Sliwa, K., Noël, A., Martial, J., Hilfiker-Kleiner, D., & Struman, I. (2013). MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy. Journal of Clinical Investigation, 123 (5), 2143-54. doi:10.1172/JCI64365

LAMBERT, V., Lecomte, J., Hansen, S., Blacher, S., Alvarez Gonzalez, M.-L., Struman, I., Sounni, N. E., Rozet, E., De Tullio, P., Foidart, J.-M., Rakic, J.-M., & Noël, A. (2013). Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice. Nature Protocols, 8 (11), 2197-2211. doi:10.1038/nprot.2013.135

Lecomte, J., Louis, K., Detry, B., Blacher, S., Lambert, V., Bekaert, S., Munaut, C., Paupert, J., Blaise, P., Foidart, J.-M., Rakic, J.-M., Krane, S. M., & Noël, A. (2011). Bone marrow-derived mesenchymal cells and MMP13 contribute to experimental choroidal neovascularization. Cellular and Molecular Life Sciences, 68, 677-686. doi:10.1007/s00018-010-0476-6

Sabatel, C., Malvaux, L., Bovy, N., Deroanne, C., LAMBERT, V., Alvarez Gonzalez, M.-L., Colige, A., Rakic, J.-M., Noël, A., Martial, J., & Struman, I. (2011). MicroRNA-21 Exhibits Antiangiogenic Function by Targeting RhoB Expression in Endothelial Cells. PLoS ONE, 6 (2), 16979. doi:10.1371/journal.pone.0016979

Bruyere, F.* , Melen-Lamalle, L.* , Blacher, S., Detry, B., Masset, A., Lecomte, J., Lambert, V., Maillard, C., Hoyer-Hansen, G., Lund, L. R., Foidart, J.-M., & Noël, A. (2010). Does plasminogen activator inhibitor-1 drive lymphangiogenesis? PLoS ONE, 5 (3), 9653. doi:10.1371/journal.pone.0009653
* These authors have contributed equally to this work.

Dubail, J., Kesteloot, F., Deroanne, C., Motte, P., Lambert, V., Rakic, J.-M., Lapiere, C., Nusgens, B., & Colige, A. (2010). ADAMTS-2 functions as anti-angiogenic and anti-tumoral molecule independently of its catalytic activity. Cellular and Molecular Life Sciences. doi:10.1007/s00018-010-0431-6

Hemmer, M., Kempen, I., De Tullio, P., Frankenne, F., Lambert, V., Blacher, S., Bueb, J.-L., Foidart, J.-M., Noël, A., Tschirhart, E., & Pirotte, B. (2010). New Biological Investigations on 3-Bromophenyl 6-Acetoxymethyl-2-oxo-2H-1-Benzopyran-3-Carboxylate as Anti-angiogenic Agent. Drug Development Research, 71, 1-10. doi:10.1002/ddr.20364

Jost, M., Maillard, C., Lambert, V., Tjwa, M., Blaise, P., Lecomte, J., Bajou, K., Blacher, S., Motte, P., Humblet, C., Defresne, M.-P., Thiry, M., Frankenne, F., Gothot, A., Carmeliet, P., Rakic, J.-M., Foidart, J.-M., & Noël, A. (2006). Plasminogen activator inhibitor type I (PAI-1) controls bone marrow-dependent and independent vascularization. Acta Clinica Belgica, 61 (2, MAR-APR), 87.

Lambert, V. (2005). Rôle des protéinases et de leurs inhibiteurs dans les formes associées à une néovascularisation anormale sous-rétinienne. Caractérisation par l’étude de modèles animaux transgéniques et développements thérapeutiques [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/30882

Dubail, J., Kesteloot, F., Motte, P., Lambert, V., Rakic, J.-M., Lapière, C. M., Nusgens, B., & Colige, A. (2004). Effect of ADAMTS-2, a metalloproteinase containing a disintegrin domain and thrombospondin type I repeats, during angiogenesis in vitro and in vivo. Angiogenesis, 7 (2), 172.

Rakic, J.-M., Lambert, V., Devy, L., Luttun, A., Carmeliet, P., Claes, C., Nguyen, L., Foidart, J.-M., Munaut, C., & Noël, A. (July 2003). Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization. Investigative Ophthalmology and Visual Science, 44 (7), 3186-3193. doi:10.1167/iovs.02-1092

Lambert, V., Munaut, C., Carmeliet, P., Gerard, R. D., Declerck, P. J., Gils, A., Claes, C., Foidart, J.-M., Rakic, J.-M., & Noël, A. (June 2003). Dose-dependent modulation of choroidal neovascularization by plasminogen activator inhibitor type 1: Implications for clinical trials. Investigative Ophthalmology and Visual Science, 44 (6), 2791-2797. doi:10.1167/iovs.02-1179

Rakic, J.-M., Maillard, C., Jost, M., Bajou, K., Masson, V., Devy, L., Lambert, V., Foidart, J.-M., & Noël, A. (March 2003). Role of plasminogen activator-plasmin system in tumor angiogenesis. Cellular and Molecular Life Sciences, 60 (3), 463-473. doi:10.1007/s000180300039

Lambert, V., Wielockx, B., Munaut, C., Galopin, C., Jost, M., Itoh, T., Werb, Z., Baker, A., Krell, H. W., Foidart, J.-M., Rakic, J.-M., libert, C., & Noël, A. (2003). MMP-2 and MMP-9 synergize in promoting choroidal neovascularization. FASEB Journal, 17 (15), 2290-2292. doi:10.1096/fj.03-0113fje

Rakic, J.-M., Lambert, V., Deprez, M., Foidart, J.-M., Noël, A., & Munaut, C. (2003). Estrogens reduce the expression of YKL-40 in the retina: Implications for eye and joint diseases. Investigative Ophthalmology and Visual Science, 44 (4), 1740-1746. doi:10.1167/iovs.02-0775

Lambert, V., Munaut, C., Jost, M., Werb, Z., Foidart, J.-M., Rakic, J.-M., & Noël, A. (October 2002). Matrix metalloproteinase-9 contributes to choroidal neovascularization. American Journal of Pathology, 161 (4), 1247-1253. doi:10.1016/S0002-9440(10)64401-X

Lambert, V., Munaut, C., Frankenne, F., Bajou, K., Gerard, R., Carmeliet, P., Defresne, M.-P., Foidart, J.-M., Rakic, J.-M., & Noël, A. (April 2001). Influence of Plasminogen Activator Inhibitor Type 1 on Choroidal Neovascularization. FASEB Journal, 15 (6), 1021-7. doi:10.1096/fj.00-0393com

Munaut, C., Lambert, V., Noël, A., Frankenne, F., Deprez, M., Foidart, J.-M., & Rakic, J.-M. (2001). Presence of Oestrogen Receptor Type Beta in Human Retina. British Journal of Ophthalmology, 85 (7), 877-82. doi:10.1136/bjo.85.7.877